Changing Paradigms in the Management of CLL
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Evaluate the emerging clinical trial data on novel therapeutic approaches for patients with CLL
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center
- 0.50 Participation
- 0.53 Nurse
- 0.50 Pharmacist
- 0.50 Physician